文献速递临床试验与 GCP

轻中度急性胆囊炎术前抗生素治疗(POMMAC)研究方案:一项非劣效性开放标签随机对照试验

Preoperative antibiotics for mild or moderate acute cholecystitis (POMMAC): study protocol for a non-inferiority, open-label, randomized controlled trial.
PubMed 文献 · Trials · 2026-07-25

POMMAC 试验旨在探讨单剂抗生素预防是否在术后感染方面非劣效于连续术前抗生素治疗。该研究为开放标签、非劣效性随机对照试验,计划纳入 456 例轻中度急性胆囊炎参与者,按 1:1 随机分组,主要结局为术后 30 天内感染率。

要点

  • 单剂抗生素预防可能非劣效于连续术前抗生素治疗。
  • 主要结局为术后 30 天内感染发生率。
  • 避免不必要术前抗生素或可减少耐药与医疗费用。

核心结论

  • POMMAC 试验将提供术前抗生素治疗对急性胆囊炎术后感染影响的证据。

研究设计与样本

  • 非劣效性、开放标签随机对照试验,计划纳入 456 例轻中度急性胆囊炎参与者,按 1:1 随机分组。

关键数值与推荐

  • 主要结局为术后 30 天内感染率。
  • 次要结局包括腹腔镜转开腹胆囊切除术率、其他术后并发症(Clavien-Dindo)、术后 30 天内抗生素相关超敏反应、艰难梭菌腹泻和酵母菌感染的复合结局及住院时间。

临床怎么用

  • 若单剂预防非劣效,可避免不必要的术前抗生素治疗,从而减少抗菌药物耐药、抗生素相关不良事件和医疗支出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence is lacking on the effect of preoperative antibiotic therapy on postoperative infections in acute cholecystitis. The POMMAC trial aims to investigate whether a single dose of antibiotic prophylaxis is non-inferior to continuous preoperative antibiotic therapy in terms of postoperative infections. METHODS: This is a non-inferior, open-label randomized controlled trial aiming to include 456 participants. Eligible participants with mild or moderate acute cholecystitis will be randomized at a 1:1 ratio to receive either continuous or a single dose of preoperative antibiotic prophylaxis. The primary outcome is the rate of postoperative infections within 30 days postoperatively. Secondary outcomes are rates of conversion from laparoscopic to open cholecystectomy, other postoperative complications (Clavien-Dindo), a composite outcome incorporating antibiotic-related hypersensitivity reactions, Clostridium difficile diarrhea, and yeast infections within 30 days postoperatively, and the length of stay. DISCUSSION: The POMMAC trial will provide evidence on the effect of preoperative antibiotic therapy on postoperative infections in acute cholecystitis. Abstaining from unnecessary preoperative antibiotic therapy could reduce antimicrobial resistance, adverse antibiotic-related events, and healthcare expenses. TRIAL REGISTRATION: EU CTIS: https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-515958-24-00 protocol version 2.4. Registered on April 9th, 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Terho P, Sallinen V, Lampela H, et al. Preoperative antibiotics for mild or moderate acute cholecystitis (POMMAC): study protocol for a non-inferiority, open-label, randomized controlled trial. Trials. 2026. PMID: 42902317. doi:10.1186/s13063-026-09917-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。